ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 97 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $13,488,609,000 | +26.9% | 506,900 | +5.2% | 3.49% | +50.6% |
| Q2 2016 | $10,628,100,000 | +6.8% | 482,000 | +42.2% | 2.32% | +17.2% |
| Q1 2016 | $9,952,054,000 | +83.8% | 338,851 | +106.6% | 1.98% | +228.2% |
| Q4 2015 | $5,414,818,000 | +114499.3% | 163,986 | +6.3% | 0.60% | -47.7% |
| Q1 2015 | $4,725,000 | +110.7% | 154,300 | +249.8% | 1.15% | +75.3% |
| Q4 2014 | $2,243,000 | -90.0% | 44,117 | -92.2% | 0.66% | -90.0% |
| Q3 2014 | $22,432,000 | +104.1% | 566,903 | +122.2% | 6.58% | +56.7% |
| Q2 2014 | $10,988,000 | +94.7% | 255,128 | +80.8% | 4.20% | +40.4% |
| Q1 2014 | $5,644,000 | +28.9% | 141,128 | -12.1% | 2.99% | -16.4% |
| Q4 2013 | $4,377,000 | – | 160,471 | – | 3.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |